---
title: Numbing surgical area speeds recovery
nct_id: NCT07176494
phase: NA
status: RECRUITING
sponsor: Ankara Etlik City Hospital
study_type: INTERVENTIONAL
canonical_url: "https://parkinsonspathways.com/trial/NCT07176494"
clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT07176494"
last_fetched: "2026-05-10T14:03:57.016Z"
source: "Parkinson's Pathways (curated)"
---
# Numbing surgical area speeds recovery

**Goal (in five words):** Numbing surgical area speeds recovery

**Official Title:** Revision of Deep Brain Stimulator in Patients With Parkinson's Disease: A Comparison of Perioperative Characteristics of Regional and General Anesthesia

**Trial ID:** [NCT07176494](https://clinicaltrials.gov/study/NCT07176494)

## Key Facts

- **Phase:** NA
- **Status:** RECRUITING
- **Study Type:** INTERVENTIONAL
- **Sponsor:** Ankara Etlik City Hospital
- **Target Enrollment:** 50 participants
- **Start Date:** 2025-09-20
- **Completion Date:** 2026-07-05
- **Conditions:** Pain Management, Regional Anesthesia, Deep Brain Stimulation, Parkinsons Disease
- **Interventions:** Patients who underwent surgery under general anesthesia, Patients who underwent surgery under regional anesthesia
- **Intervention Types:** PROCEDURE

## Summary For Families

The trial aims to find out whether using regional anesthesia instead of general anesthesia during revision surgery for deep brain stimulators changes perioperative outcomes like pain control, blood pressure stability, complications, and recovery time. It compares patients who have the surgery under general anesthesia, which makes you fully unconscious, with those who have regional anesthesia, which numbs the surgical area and may let you remain more awake, tracking things like intraoperative stability, postoperative pain, and how quickly you recover. Because anesthesia affects breathing, blood pressure, and how soon you can resume Parkinson medications, the study looks at these practical effects for people on treatments such as levodopa. Adults aged 40 to 85 with an ASA score of I to III and a BMI between 18 and 30 are eligible.

## Eligibility

- **Minimum age:** 40 Years
- **Maximum age:** 85 Years
- **Sex:** ALL

### Full Criteria

```
Inclusion Criteria:

* Those aged 40-85
* Those with an ASA score of I-II-III
* Those with a body mass index (BMI) between 18-30

Exclusion Criteria:

* Those under 40 and over 85
* Those with an ASA score of IV or higher
* Those with a BMI of under 18 and over 30
```

## Locations (1)

- Ankara Etlik City Hospital, Ankara, Yenimahalle\Ankara, Turkey (Türkiye) _(39.9199, 32.8543)_
  - İbrahim MD Topcu — (CONTACT) — 05437860316 — ibrahimtpc78@gmail.com
  - Musa Assoc.Prof Zengin — (CONTACT) — 00905307716235 — musazengin@gmail.com

## Central Contacts

- İbrahim MD Topcu, MD — (CONTACT) — 05437860316 — ibrahimtpc78@gmail.com
- Musa MD Zengin — (CONTACT) — +905307716235 — musazengin@gmail.com

---

*Canonical: https://parkinsonspathways.com/trial/NCT07176494*  
*HTML version: https://parkinsonspathways.com/trial/NCT07176494*  
*Source data: https://clinicaltrials.gov/study/NCT07176494*